Stockscreener 앱 받기
23.50
0.32%
-0.075
시간 외 거래:
23.50
0.005
+0.02%
전일 마감가:
$23.57
열려 있는:
$24.38
하루 거래량:
467.08K
Relative Volume:
3.07
시가총액:
$386.56M
수익:
$105.65M
순이익/손실:
$-216.77M
주가수익비율:
-1.3236
EPS:
-17.7511
순현금흐름:
$-225.11M
1주 성능:
+7.85%
1개월 성능:
+14.95%
6개월 성능:
+171.21%
1년 성능:
+213.27%
1일 변동 폭
$23.05
$26.34
1주일 범위
$19.11
$26.34
52주 변동 폭
$5.231
$26.54
Sutro Biopharma Inc Stock (STRO) Company Profile
명칭
Sutro Biopharma Inc
전화
650-392-8412
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Compare STRO vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
23.50 | 387.79M | 105.65M | -216.77M | -225.11M | -17.75 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-20 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-06-16 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-03-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2024-05-08 | 개시 | BofA Securities | Buy |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-06 | 개시 | Oppenheimer | Outperform |
| 2023-03-21 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 재개 | Wells Fargo | Overweight |
| 2021-06-18 | 개시 | H.C. Wainwright | Buy |
| 2020-12-03 | 개시 | Stifel | Buy |
| 2020-09-02 | 개시 | Jefferies | Buy |
| 2020-07-16 | 개시 | Wells Fargo | Overweight |
| 2020-01-13 | 개시 | SunTrust | Buy |
| 2019-10-07 | 개시 | BTIG Research | Buy |
| 2019-07-18 | 개시 | Deutsche Bank | Buy |
| 2019-04-29 | 개시 | H.C. Wainwright | Buy |
| 2018-10-22 | 개시 | JMP Securities | Mkt Outperform |
| 2018-10-22 | 개시 | Piper Jaffray | Overweight |
| 2018-10-22 | 개시 | Wedbush | Outperform |
모두보기
Sutro Biopharma Inc 주식(STRO)의 최신 뉴스
Analyst James Shin Raises Price Target for Sutro Biopharma (STRO) to $55.00 | STRO Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Sutro Biopharma (NASDAQ:STRO) Stock Price - MarketBeat
Deutsche Bank Adjusts Sutro Biopharma Price Target to $55 From $51, Maintains Buy Rating - marketscreener.com
HC Wainwright Predicts Sutro Biopharma FY2030 Earnings - MarketBeat
This Ralph Lauren Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Wells Fargo Upgrades Sutro Biopharma (STRO) with Significant Pri - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Raised to "Overweight" at Wells Fargo & Company - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Raised to Buy at HC Wainwright - MarketBeat
Wells Fargo Upgrades Sutro Biopharma to Overweight From Equal Weight, Adjusts PT to $27 From $8 - marketscreener.com
H.C. Wainwright upgrades Sutro Biopharma stock rating to buy By Investing.com - Investing.com Canada
Sutro's FY25 Net Loss Narrows; On Track To Report Initial Phase 1 Data Of STRO-004 In Mid-2026 - RTTNews
STRO Stock: HC Wainwright & Co. Upgrades Sutro Biopharma | STRO Stock News - GuruFocus
Sutro Biopharma (STRO) Receives Upgrade with Promising Outlook - GuruFocus
Sutro Biopharma Reports 2025 Financial Results, Advances Dual-Payload ADC Pipeline, and Extends Cash Runway to 2028 - Minichart
HC Wainwright & Co. upgrades Sutro Biopharma (STRO) - MSN
Sutro Biopharma Annual Report 2023: Business Overview, Risk Factors, and Financial Analysis - Minichart
Sutro Biopharma (NASDAQ: STRO) launches $100M ATM program with TD Cowen - Stock Titan
Sutro Biopharma Ends ATM Agreement After 2025 Results - TipRanks
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights - Bitget
Sutro Biopharma (NASDAQ:STRO) Issues Earnings Results - MarketBeat
Sutro Biopharma 2025 10-K: $102.5M revenue, $(22.49) EPS - TradingView
Sutro Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Sutro Biopharma (NASDAQ: STRO) expands ADC pipeline and monetizes partnerships - Stock Titan
Revenue jumps as Sutro Biopharma (NASDAQ: STRO) narrows 2025 loss - Stock Titan
Q4 financial results released by Sutro Biopharma with operational update - Traders Union
BRIEF-Sutro Biopharma FY Revenue USD 102.484 Million Vs. IBES Estimate USD 99.2 Million - TradingView
Sutro says cash lasts to 2028 as cancer drug pipeline advances - Stock Titan
Sutro Biopharma (STRO) 2024 Wells Fargo Healthcare Conference Summary - Quartr
If You Invested $1,000 in Sutro Biopharma (STRO) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Analyst Upgrade: Is now the right time to enter Sutro Biopharma Inc2026 Summary & Community Consensus Trade Alerts - baoquankhu1.vn
Aug Action: What are Sutro Biopharma Inc.’s recent SEC filings showing2026 Retail Activity & AI Based Trade Execution Alerts - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Aug Rallies: Why is Allegro MicroSystems Inc. stock going down2026 Update & Accurate Trade Setup Notifications - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 19.8% in February - MarketBeat
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 (NASDAQ:STRO) - Seeking Alpha
Sutro Biopharma, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 - Quiver Quantitative
Fed Meeting: What is the Moat Score of Sutro Biopharma Inc2026 Retail & Daily Growth Stock Tips - baoquankhu1.vn
Sutro Biopharma (STRO) surges 11.9%: Is this an indication of further gains? - MSN
Sutro Biopharma Hits New 52-Week High of $25.68, Soars 556.88% - Markets Mojo
Sutro Biopharma Inc expected to post a loss of $4.34 a shareEarnings Preview - TradingView
Aug Swings: Can Sutro Biopharma Inc. continue delivering strong returns2026 Pullback Review & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Sutro Biopharma Hits New 52-Week High of $21.40, Soars 453% - Markets Mojo
Sutro Biopharma (STRO) GC exercises RSUs as shares withheld for taxes - Stock Titan
Sutro Biopharma Hits New 52-Week High at $20.47, Soars 430% - Markets Mojo
Sutro Biopharma Hits New 52-Week High of $20.93, Up 431.69% - Markets Mojo
Sutro Biopharma Hits New 52-Week High of $20.48, Up 431.69% - Markets Mojo
Sutro Biopharma (STRO) to Release Quarterly Earnings on Thursday - MarketBeat
Sutro Biopharma: Transformed leadership and advanced ADC pipeline drive clinical progress, with key data due mid-year - TradingView
Sutro Biopharma: Transformed leadership and advanced ADC platform drive rapid clinical progress and innovation - TradingView
Sutro Biopharma (STRO) GC reports new RSUs, options and tax share withholdings - Stock Titan
Sutro Biopharma Inc (STRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):